GAMMA Investing
FENC icon

GAMMA Investing’s Fennec Pharmaceuticals FENC Stock Holding History

GAMMA Investing’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.89K Buy
459
+110
+32% +$1.21K ﹤0.01% 3657
2026
Q2 		$3.75K Buy
349
+265
+315% +$2.16K ﹤0.01% 3587
2026
Q1 		$517 Sell
84
-29
-26% -$224 ﹤0.01% 3944
2025
Q4 		$870 Hold
113
– – ﹤0.01% 3819
2025
Q3 		$1.06K Hold
113
– – ﹤0.01% 3604
2025
Q2 		$938 Buy
113
+3
+3% +$21 ﹤0.01% 3544
2025
Q1 		$670 Buy
+110
New +$706 ﹤0.01% 3634

Other funds holding FENC

State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing's FENC Position: Q3 2026 in Review

GAMMA Investing increased its Fennec Pharmaceuticals (FENC) stake by 32% in Q3 2026, buying an estimated $1.21K and bringing the position to 459 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

GAMMA Investing first reported a position in FENC in Q1 2025 and has held it in 7 quarters since. 9 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • GAMMA Investing held 459 shares of Fennec Pharmaceuticals worth $4.89K as of Q3 2026.
  • GAMMA Investing bought 110 Fennec Pharmaceuticals shares in Q3 2026, an estimated $1.21K.
  • Fennec Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3657 holding.
  • GAMMA Investing first reported a position in Fennec Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • 9 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.